In its most recent earnings release on Nov. 10, CRISPR said that Vertex has been seeing progress in the number of patients (currently around 300) being referred to treatment centers. Vertex sees ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Detailed price information for Ark Genomic Revolution ETF (ARKG-A) from The Globe and Mail including charting and trades.

These stocks have promising assets in their portfolios that could help make their valuations soar in the future.